Clinical Trial Update: Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE) [Phase 2]

View source ↗

Summary

Phase 2 trial of rifaximin soluble solid dispersion tablets plus lactulose for overt hepatic encephalopathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overt Hepatic Encephalopathy

Drugs mentioned

• LACTULOSE (Lactulose)
• Rifaximin SSD tablets (rifaximin)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Overt Hepatic Encephalopathy | Phase 2 | Status: COMPLETED | Results posted: 2023-04-13